The At-Home Saliva Testing Kit Market is expanding as consumers seek convenient, non-invasive, and accessible ways to monitor health from home. Saliva collection does not require needles and can support testing for genetic traits, hormones, infections, drugs, oral health, and other biomarkers. At-home saliva kits typically include a collection tube or swab, instructions, packaging for...

NEWARK, Del., October 9, 2026. — The global hepatic sarcopenia nutrition market is estimated at USD 142.2 million in 2026 and is projected to reach USD 342.8 million by 2036, expanding at a CAGR of 9.2% from 2026 to 2036, according to Future Market Insights (FMI). The market stood at USD 130.2 million in 2025. The growth outlook is being shaped by increasing demand for specialized...

Market Overview The biologic therapy market is undergoing a transformative shift with the rise of biosimilars, which are highly similar versions of approved biologics that offer comparable efficacy and safety at lower costs. Biosimilars are expanding patient access to life-changing treatments for cancer, autoimmune diseases, and diabetes. The market is projected to grow through 2030, driven by...

Biohacking Market Biohacking Market Accelerated by AI Biomarker Tracking and Personalized Health Optimization The rapid shift toward proactive, self-directed health management is accelerating adoption across individual consumer and clinical demographics alike. According to market research on the Biohacking Market, rising interest in healthy lifespan extension, performance optimization, and...

Market OverviewCardiovascular disease treatment is driving fixed-dose combination drug adoption as hypertension, dyslipidemia, and heart failure patients increasingly require multiple medications to achieve therapeutic targets. Single-tablet combinations of antihypertensives, statins, and antiplatelet agents are becoming standard of care, reducing pill burden and improving adherence for...